gca and risk of cancer or visual loss
Published 4 years ago • 159 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
23:18
new therapies for pmr & gca
-
19:01
giant cell arteritis (temporal arteritis) | causes, pathophysiology, symptoms, diagnosis, treatment
-
4:34
gca treatment data: dr. david liew
-
2:02
understanding giant cell arteritis (gca): causes, symptoms, and treatment
-
19:49
gca pmr panel from eular2020
-
0:36
5 signs of giant cell arteritis that you should know about
-
7:59
giant cell arteritis (temporal arteritis)
-
10:07
giant cell arteritis and takayasu arteritis (large vessel vasculitis) - signs, pathophysiology
-
0:48
criteria for diagnosis of giant cell arteritis
-
3:03
blindness with tocilizumab in gca: is it a worry? dr. david liew
-
1:46
dr. kathryn dao on giant cell arteritis and vasculitis
-
1:00
giant cell arteritis - signs you should not ignore
-
3:33
much gusto for gusto: efficacy of tocilizumab monotherapy for giant cell arteritis
-
7:24
gca: normal dose of prednisone? - giant cell arteritis treatment
-
5:25
pet/ct has good accuracy for diagnosing gca
-
3:34
giant cell arteritis
-
12:09
giant cell arteritis (gca) / temporal arteritis - all you need to know i dr shaz rehan, 2022
-
36:00
gca webinar part 1
-
2:36
gca: what we feel and what we can't